View Item 

Show simple item record

Antifibrillatory effects of clofilium in the rabbit isolated heart
dc.contributor.authorFriedrichs, Gregory S.en_US
dc.contributor.authorChi, Liguoen_US
dc.contributor.authorGreen, Alysia L.en_US
dc.contributor.authorLucchesi, Benedict R.en_US
dc.date.accessioned2012-08-09T14:57:07Z
dc.date.available2012-08-09T14:57:07Z
dc.date.issued1994-09en_US
dc.identifier.citationFriedrichs, Gregory S.; Chi, Liguo; Green, Alysia L.; Lucchesi, Benedict R. (1994). "Antifibrillatory effects of clofilium in the rabbit isolated heart." British Journal of Pharmacology 113(1). <http://hdl.handle.net/2027.42/92452>en_US
dc.identifier.issn0007-1188en_US
dc.identifier.issn1476-5381en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/92452
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherRabbit Isolated Hearten_US
dc.subject.otherChemical Defibrillationen_US
dc.subject.otherUK‐68,798en_US
dc.subject.otherClofiliumen_US
dc.subject.otherClass III Antiarrhythmic Drugsen_US
dc.subject.otherVentricular Fibrillationen_US
dc.subject.other5‐Hydroxydecanoateen_US
dc.subject.otherATP‐Dependent K + Channelsen_US
dc.titleAntifibrillatory effects of clofilium in the rabbit isolated hearten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Department of Pharmacology, M6322 Medical Science Building I, Ann Arbor, Michigan 48109‐0626 U.S.A.en_US
dc.identifier.pmid7812612en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/92452/1/j.1476-5381.1994.tb16195.x.pdf
dc.identifier.doi10.1111/j.1476-5381.1994.tb16195.xen_US
dc.identifier.sourceBritish Journal of Pharmacologyen_US
dc.identifier.citedreferenceNOMA, A. ( 1983 ). ATP‐regulated K + channels in cardiac muscle. Nature, 305, 147 – 148.en_US
dc.identifier.citedreferenceDORIAN, P., WANG, M., DAVID, I. & FEINDEL, C. ( 1991 ). Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model. Circulation, 83, 614 – 621.en_US
dc.identifier.citedreferenceGOUGH, W.B., HU, D. & el SHERIF, N. ( 1988 ). Effects of clofilium on ischemic subendocardial Purkinje fibers 1 day post‐infarction. J. Am. Coll. Cardiol., 11, 431 – 437.en_US
dc.identifier.citedreferenceGREENE, H.L., WERNER, J.A., GROSS, B.W., SEARS, G.K., TROBAUGH, G.B. & COBB, L.A. ( 1993 ). Prolongation of cardiac refractory times in man by clofilium phosphate, a new antiarrhythmic agent. Am. Heart J., 106, 492 – 500.en_US
dc.identifier.citedreferenceGWILT, M., DALRYMPLE, H.W., BURGES, R.A., BLACKBURN, K.J., ARROWSMITH, J.E., CROSS, P.E. & HIGGINS, A.J. ( 1989 ). UK‐68,798 is a novel, potent and selective class III antiarrhythmic agent. J. Mol. Cell. Cardiol., 21, S11.en_US
dc.identifier.citedreferenceKOPIA, G.A., ELLER, B.T., PATTERSON, E., SHEA, M.J. & LUCCHESI, B.R. ( 1985 ). Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models. Eur. J. Pharmacol., 116, 49 – 61.en_US
dc.identifier.citedreferenceKOWEY, P.R., FRIEHLING, T.D., O'CONNER, K.M., WETSTEIN, L. & KELLIHER, G.J. ( 1985 ). The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart. Am. Heart J., 110, 363 – 370.en_US
dc.identifier.citedreferenceLI, T., CARR, A.A. & DAGE, R.C. ( 1990 ). Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol. J. Cardiovasc. Pharmacol., 16, 917 – 923.en_US
dc.identifier.citedreferenceLINDSTROM, T.D., MURPHY, P.J., SMALLWOOD, J.K., WIEST, S.A. & STEINBERG, M.I. ( 1982 ). Correlation between the disposition of [14C] clofilium and its cardiac electrophysiological effects. J. Pharmacol. Exp. Ther., 221, 584 – 589.en_US
dc.identifier.citedreferenceLYNCH, J.J., WILBER, D.J., MONTGOMERY, D.G., HSIEH, T.M., PATTERSON, E. & LUCCHESHI, B.R. ( 1984 ). Antiarrhythmic and antifibrillatory actions of the levo‐ and dextro‐rotary isomers of sotalol. J. Cardiovasc. Pharmacol., 6, 1132 – 1141.en_US
dc.identifier.citedreferenceLYNCH, J.J., WILBER, D., MONTGOMERY, D.G., HSIEH, T.M., PATTERSON, E. & LUCCHESHI, B.R. ( 1989 ). Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction (abstr). J. Mol. Cell. Cardiol., 21 ( Suppl II ), S154.en_US
dc.identifier.citedreferenceMARTIN, C.L. & CHINN, K. ( 1990 ). Pinacidil opens ATP‐dependent K + channels in cardiac myocytes in an ATP and temperature dependent manner. J. Cardiovasc. Pharmacol., 15, 510 – 514.en_US
dc.identifier.citedreferenceNETTLETON, J., CASTLE, N.A. & WANG, G.K. ( 1991 ). Block of single batrachotoxin‐activated Na + channels by clofilium. Mol. Pharmacol., 39, 352 – 358.en_US
dc.identifier.citedreferenceNIHO, T., NOTSU, T., ISHIKAWA, H., FUNATO, H., YAMAZAKI, M., TAKAHASHI, H., TANAKA, I., KAYAMOTO, M., DABASKI, F., SHINKAWA, T., UEMURA, A. & MIZOTA, M. ( 1987 ). Study of mechanisms and effects of sodium 5‐hydroxydecanoate on experimental ischemic ventricular arrhythmia. Folia Pharmacol. (Japan), 89, 155 – 167.en_US
dc.identifier.citedreferenceNOTSU, T., OHHASHI, K., TANAKA, I., ISHIKAWA, H., NIHO, T., FUKUTAKE, K. & MIZOTA, M. ( 1992 ). 5‐Hydroxydecanoate inhibits ATP‐sensitive K+ channel currents in guinea‐pig single ventricular myocytes. Eur. J. Pharmacol., 220, 35 – 41.en_US
dc.identifier.citedreferenceNOTSUTO, T., TANAKA, I., TAKANO, M. & NOMA, A. ( 1992 ). Blockade of the ATP‐sensitive K + channel by 5‐hydroxydecanoate in guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther., 260, 702 – 708.en_US
dc.identifier.citedreferencePATTERSON, E., ELLER, B.T., ABRAMS, G.D., VASILIADES, J. & LUCCHESI, B.R. ( 1983 ). Ventricular fibrillation in a conscious canine preparation of sudden coronary death. Prevention by short and long‐term amiodarone administration. Circulation, 68, 857 – 864.en_US
dc.identifier.citedreferenceRASMUSSEN, H.S., ALLEN, M.J., BLACKBURN, K.J., BUTROUS, G.S. & DALRYMPLE, H.W. ( 1992 ). Dofetilide, a novel class III antiarrhythmic agent. J. Cardiovasc. Pharmacol., 20 ( Suppl 2 ), S96 – S1051.en_US
dc.identifier.citedreferenceREEVE, H.L. & PEERS, C. ( 1992 ). Blockade of delayed rectifier K + currents in neuroblastoma X glioma hybrid (NG 108–15) cells by clofilium, a class III antidysrhythmic agent. Br. J. Pharmacol., 105, 458 – 462.en_US
dc.identifier.citedreferenceSAKUTA, H., OKAMOTO, K. & WATANABE, Y. ( 1993 ). Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide‐sensitive K+ currents in Xenopus oocytes. Br. J. Pharmacol., 109, 866 – 872.en_US
dc.identifier.citedreferenceSANNA, G. & ARCIDIACONO, R. ( 1973 ). Chemical ventricular defibrillation of the human heart with bretylium tosylate Am. J. Cardiol., 32, 982 – 987.en_US
dc.identifier.citedreferenceSYNDERS, D.J. & KATZUNG, B.G. ( 1985 ). Clofilium reduces the plateau potassium current in isolated cardiac myocytes. Circulation, 72 ( Suppl III ), 233.en_US
dc.identifier.citedreferenceSPINELLI, W., PARSONS, R.W. & COLATSKY, T.J. ( 1992 ). Effects of WAY‐123,398, a new Class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK‐68798, E‐4031, and dl‐Sotalol. J. Cardiovasc. Pharmacol., 20, 913 – 922.en_US
dc.identifier.citedreferenceSTEINBERG, M.I. & MOLLOY, B.B. ( 1975 ). Clofilium‐a new antifibrillatory agent that selectively increases cellular refractoriness. Life Sci., 25, 1397 – 1406.en_US
dc.identifier.citedreferenceSTEINBERG, M.I., SULLIVAN, M.E., WIEST, S.A., ROCKHOLD, F.W. & MOLLOY, B.B. ( 1981 ). Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers. J. Cardiovasc. Pharmacol., 3, 881 – 895.en_US
dc.identifier.citedreferenceWU, K.‐M., ROSS, S. & HOFFMAN, B.F. ( 1989 ). Monophasic action potentials during reentrant atrial flutter in the dog: effects of clofilium and acetylcholine. J. Cardiovasc. Pharmacol., 13, 908 – 914.en_US
dc.identifier.citedreferenceARENA, J.P. & KASS, R.A. ( 1988 ). Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. Mol. Pharmacol., 34, 60 – 66.en_US
dc.identifier.citedreferenceARENA, J.P. & KASS, R.S. ( 1989 ). Activation of ATP sensitive K channels in heart cells by pinaicidil: dependence on ATP. Am. J. Physiol., 257 (Heart Circ Physiol 26), H2092 – H2096.en_US
dc.identifier.citedreferenceBACANER, M. ( 1968 ). Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. Am. J. Cardiol., 21, 530 – 543.en_US
dc.identifier.citedreferenceBLACK, S.C., CHI, L., MU, D.‐X. & LUCCESHI, B.R. ( 1991 ). The antifibrillatory actions of UK‐68,798, a Class III antiarrhythmic agent. J. Pharmacol. Exp. Ther., 258, 416 – 423.en_US
dc.identifier.citedreferenceBOURA, A.L.A. & GREEN, A.F. ( 1959 ). The action of bretylium: adrenergic neuron blocking and other effects. Br. J. Pharmacol. Chemother., 14, 536 – 548.en_US
dc.identifier.citedreferenceCARLSSON, L., ABRAHAMSSON, C., DREWS, L. & DUKER, G. ( 1992 ). Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation, 85, 1491 – 1500.en_US
dc.identifier.citedreferenceCARMELIET, E. ( 1992 ). Voltage‐ and time‐dependent block of the delayed K + current in cardiac myocytes by dofetilide. J. Pharmacol. Exp. Ther., 262, 809 – 817.en_US
dc.identifier.citedreferenceCASTLE, N.A. ( 1991 ). Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homology. J. Pharmacol. Exp. Ther., 257, 342 – 350.en_US
dc.identifier.citedreferenceCHI, L., BLACK, S.C., KUO, P.I., FAGBEMI, S.O. & LUCCHESI, B.R. ( 1993 ). Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP‐dependent potassium channel. J. Cardiovasc. Pharmacol., 21, 179 – 190.en_US
dc.identifier.citedreferenceCHI, L., MU, D.‐X., DRISCOLL, E.M. & LUCCHESI, B.R. ( 1990a ). Antiarrhythmic and electrophysiologic actions of CK‐3579 and sematilide in a conscious canine model of sudden coronary death. J. Cardiovasc. Pharmacol., 16, 312 – 324.en_US
dc.identifier.citedreferenceCHI, L., U'PRICHARD, A.C.G. & LUCCHESI, B.R. ( 1990b ). Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J. Cardiovasc. Pharmacol., 15, 452 – 464.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1476-5381.1994.tb16195.x.pdf
Size:
1.522MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.